Elisabeth de Vries

Prof. Elisabeth de Vries is a Professor in the Faculty of Medical Sciences at the University of Groningen. Her research focuses on oncology, molecular imaging, and clinical trial design, with particular expertise in cancer medicines and immunotherapy biomarkers. She holds leadership roles in global oncology organizations such as the European Society for Medical Oncology (ESMO) and chairs the WHO Essential Medicines List Cancer Working Group.

• Member of the Royal Netherlands Academy of Arts and Sciences (KNAW) since 2002
• Chair of the WHO Essential Medicines List Cancer Working Group
• Co-Chair of the RECIST committee

Her research emphasizes optimizing cancer drug access, improving treatment efficacy through molecular imaging, and developing prognostic biomarkers. Recent work includes studies on CD8 T-cell dynamics in melanoma and transcriptional patterns in ovarian cancer.

She has received Institutional Financial Support for advisory roles with pharmaceutical companies like Amgen and Roche. Notable awards include her KNAW membership and leadership roles in global oncology initiatives.